Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Ciba-Geigy discloses glycine-site NMDA antagonists

June 7, 1996

BASF reports glutamate receptor antagonists

June 7, 1996

GR-205171: A non-peptide neurokinin NK1 antagonist

June 7, 1996

ADIR reports piperazines with affinity for sigma-receptors

June 7, 1996

Botulinum toxin type A: Treatment of choice for idiopathic cervical dystonia

June 7, 1996

Connective Therapeutics' peptide vaccine trial results presented

June 7, 1996

CellPro and Northwestern University commence first BMT clinical trial in MS patients

June 7, 1996

Cytokine polypeptides described by Immunex

June 7, 1996

Elan acquires rights to diazepam gel formulation

June 7, 1996

Trials expected to begin on CoCensys' CCD-1042

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...